Method of treating endothelial dysfunction comprising administration of a thrombin peptide derivative

Thumbnail
View/ Open
Date
2012-12-18
Author
Metadata
Show full item record
Abstract
Endothelial dysfunction (ED) is associated with a number of diseases and disorders. Agonists of the non-proteolytically activated thrombin receptor can be used in methods to treat ED or ED-related diseases and disorders.
URI
https://hdl.handle.net/1969.1/177014
Subject
514/15.7
514/15.1
514/21.4
514/21.5
514/917
530/326
530/327
A61P 19/02
A61P 39/06
A61P 1/16
A61P 9/08
A61K 38/4833
A61P 9/10
A61P 3/10
A61P 9/00
A61K 38/16
A61P 13/12
A61P 29/00
A61P 43/00
A61K 38/10
A61P 7/02
A61P 9/12
A61P 25/28
A61P 11/00
A61P 9/14
A61K 38/18
A61P 31/04
A61P 1/00
A61P 1/04
C12Y 304/21005
A61P 5/14
A61P 11/06
A61P 15/10
A61P 39/00
C12N 9/6429
A61P 9/04
A61P 19/0
A61P 7/00
Collections
Citation
Carney, Darrell H.; Olszewska-pazdrak, Barbara; Fossum, Theresa W. (2012). Method of treating endothelial dysfunction comprising administration of a thrombin peptide derivative. United States. Patent and Trademark Office; Texas A&M University. Libraries. Available electronically from https : / /hdl .handle .net /1969 .1 /177014.